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Background: Y. enterocolitica biotype (BT) 1A strains are often isolated from human clinical samples but their
contribution to disease has remained a controversial topic. Variation and the population structure among the
clinical Y. enterocolitica BT 1A isolates have been poorly characterized. We used multi-locus sequence typing (MLST),
16S rRNA gene sequencing, PCR for ystA and ystB, lipopolysaccharide analysis, phage typing, human serum
complement killing assay and analysis of the symptoms of the patients to characterize 298 clinical Y. enterocolitica
BT 1A isolates in order to evaluate their relatedness and pathogenic potential.
Results: A subset of 71 BT 1A strains, selected based on their varying LPS patterns, were subjected to detailed
genetic analyses. The MLST on seven house-keeping genes (adk, argA, aroA, glnA, gyrB, thrA, trpE) conducted on 43
of the strains discriminated them into 39 MLST-types. By Bayesian analysis of the population structure (BAPS) the
strains clustered conclusively into two distinct lineages, i.e. Genetic groups 1 and 2. The strains of Genetic group 1
were more closely related (97% similarity) to the pathogenic bio/serotype 4/O:3 strains than Genetic group 2 strains
(95% similarity). Further comparison of the 16S rRNA genes of the BT 1A strains indicated that altogether 17 of the
71 strains belong to Genetic group 2. On the 16S rRNA analysis, these 17 strains were only 98% similar to the
previously identified subspecies of Y. enterocolitica. The strains of Genetic group 2 were uniform in their
pathogenecity-related properties: they lacked the ystB gene, belonged to the same LPS subtype or were of rough
type, were all resistant to the five tested yersiniophages, were largely resistant to serum complement and did not
ferment fucose. The 54 strains in Genetic group 1 showed much more variation in these properties. The most
commonly detected LPS types were similar to the LPS types of reference strains with serotypes O:6,30 and O:6,31
(37%), O:7,8 (19%) and O:5 (15%).
Conclusions: The results of the present study strengthen the assertion that strains classified as Y. enterocolitica BT
1A represent more than one subspecies. Especially the BT 1A strains in our Genetic group 2 commonly showed
resistance to human serum complement killing, which may indicate pathogenic potential for these strains.
However, their virulence mechanisms remain unknown.
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Yersinia enterocolitica species has six biotypes (BTs) of
which five (1B, 2, 3, 4, 5) contain pathogenic strains. Y.
enterocolitica ssp. enterocolitica consists mainly of the
strains of BT 1B, which are considered highly virulent.
Low-virulent ssp. palearctica encompasses BTs 2–5 and
1A. Since BT 1A strains lack most of the classical viru-
lence markers, this biotype is often considered non-
pathogenic. Nevertheless, BT 1A strains are commonly
isolated from patients with diarrhoea. Reports support-
ing the pathogenicity of some BT 1A strains comprise
clinical data [1-7] and cell experiments [8-10]. A viru-
lence marker commonly found in BT 1A strains is the
gene ystB encoding heat-stable Yersinia enterotoxin B
whereas they usually lack the ystA gene found from Y.
enterocolitica 4/O:3 strains. Yersinia enterotoxins A and
B are homologues to enterotoxins found in enterotoxi-
genic E. coli (ETEC) and Vibrio cholerae non-O1 strains
[11]. Higher rates of diarrhoea, weight loss, and death
have been detected when young rabbits were infected
with a Y. enterocolitica strain that produces heat-stable
enterotoxin compared to the infection with a knock-out
mutant [12]. A majority of the Y. enterocolitica BT 1A
strains possess the ystB gene [13] and some excrete
heat-stable YstB enterotoxin at 37°C in experimental
conditions corresponding to those found in ileum
[14,15].
The BT 1A strains are genetically the most heteroge-
neous of all the Y. enterocolitica biotypes [16-19]. They
belong to numerous serotypes, with at least 17 having
been identified [20]. It has been suggested that BT 1A
should be separated into its own subspecies based on
genetic differences on a DNA microarray against Y.
enterocolitica ssp. enterocolitica BT 1B strain 8081 [17].
Likewise, a number of other studies utilizing different
methods have suggested that Y. enterocolitica BT
1A strains could be divided into two main clusters
[16,21-25]. However, since the studies have been con-
ducted on different sets of strains, it is impossible to
know whether all the methods would divide the strains
into two clusters similarly. Recently, two genome
sequences of BT 1A strains with no evident structural
differences were published [26]. Notable differences be-
tween an environmental serotype O:36 and a clinical BT
1A/O:5 strains were the presence of a Rtx toxin-like
gene cluster and remnants of a P2-like prophage in the
clinical BT 1A/O:5 isolate [26].
BT 1A was the predominant biotype of Y. enteroco-
litica detected among Yersinia isolates from human
clinical stool samples in Finland in 2006 [27], as also
in other European countries [28]. Of the Finnish
patients with a BT 1A strain, 90% suffered from diar-
rhoea and abdominal pain, but only 35% had fever.
Furthermore, 3% of the patients had reactive arthritiscompared to 0.3% of the controls [7]. We hypothesized
that certain BT 1A strains might have a higher patho-
genic potential than others. In order to study this, the
clinical BT 1A isolates were investigated using multilocus
sequence typing (MLST), 16S rRNA sequencing, yst-
PCR, lipopolysaccharide (LPS) analysis, sensitivity to five
yersiniophages and serum killing assay. MLST results
were analysed with BAPS (Bayesian Analysis of Popula-
tion Structure) program, genetic and phenotypic charac-
teristics of the BT 1A strains were compared and
statistical analysis was applied to assess their correlation
with the symptoms of the patients.
Results
Genetic population structure and phylogeny
In the MLST analysis, a subset of 43 Y. enterocolitica BT
1A strains were discriminated into 39 MLST types and
the 10 4/O:3, 3/O:3 or 2/O:9 strains were discriminated
into four different MLST types. The genetic diversity in-
dexes for the genes used in MLST were 0.86 (adk), 0.93
(argA), 0.93 (aroA), 0.83 (glnA), 0.82 (gyrB), 0.94 (thrA)
and 0.89 (trpE). Bayesian analysis of the MLST
sequences divided the BT 1A strains into two distinct
genetic clusters, which were clearly separated from the
tight cluster formed by the strains of BT’s 2–4 and from
the BT 1B strain (8018) (Figure 1). One of the BT 1A
clusters contained 36 BT 1A and two non-biotypeable
strains and was designated as BT 1A Genetic group 1.
Another cluster contained five BT 1A strains and was
designated as BT 1A Genetic group 2. Ten bio/serotype
3-4/O:3 and 2/O:9 strains clustered closely together, and
the single BT 1B strain was located in the vicinity of this
cluster. BAPS analysis did not indicate any significant
level of mosaicism among the isolates, i.e. no isolates
contained variation typical to more than one cluster.
When concatenated MLST sequences (4580 bp) were
compared to each other, the BT 1A Genetic group 2
strains were 95–96% similar to BT 1A Genetic group 1,
bio/serotype 4/O:3 and 2/O:9, as well as to Y. enterocoli-
tica ssp. enterocolitica strains of biotype 1B (Table 1).
The BT 1A Genetic group 1 strains were 97% similar to
bio/serotype 4/O:3 and 2/O:9 and Y. enterocolitica ssp.
enterocolitica strains (Table 1). A neighbour-joining tree
depicting the relatedness of the selected Yersinia strains
and species based on the MLST sequence concatenates
is shown in an additional file (Additional file 1).
Comparison of the partial 16S rRNA gene sequences
(1310 bp) revealed BT 1A Genetic group 2 strains to
have over 99% similarity among themselves, 98–99%
similarity to Genetic group 1 strains and 98% similarity
to Y. enterocolitica BT 2-4/O:3 or O:9 strains (Table 2).
Actually, the 16S rRNA gene sequences of BT 1A Gen-
etic group 2 were more similar (99%) to Y. intermedia,
Y. mollaretii, Y. aldovae and Y. bercovieri than to BT
Figure 1 Maximum likelihood tree based on the MLST of seven
house-keeping genes of Y. enterocolitica strains. Color-coding
indicates the BAPS groups. The BT 1A strains were divided into two
clusters indicated in blue (Genetic group 1) and yellow (Genetic
group 2). Strains of BT’s 2–4 are indicated in red and the BT 1B strain
in green.
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obtained from representative subsets of 71 strains and
analysed using 16S rRNA gene sequencing and MLST
were combined, two genetic groups were formed: 17
strains were in Genetic group 2 and 54 in Genetic
group 1.
Of all the BT 1A Genetic group 1 strains included in
the MLST analysis, none were ystA positive in PCR, but
98% were ystB positive. All five of the BT 1A Genetic
group 2 strains were both ystA and ystB negative in
PCR. The 4/O:3, 3/O:3 and 2/O:9 strains were all ystA
positive and ystB negative in PCR. When also the BT 1A
strains that were not included in the MLST analysis were
tested for ystA and ystB, 12 further strains were found to
be negative in ystB PCR. They were also subjected to
16S rRNA gene sequencing and were found to be part of
BT 1A Genetic group 2 (Figure 2).Phenotypic characteristics
Based on the characteristics of the lipopolysaccrarides
(LPS) in silver-stained DOC-PAGE gels, the 298 Y.
enterocolitica BT 1A strains were classified into four
main LPS types (A-D), with each containing several sub-
types (Table 3). The subtype characteristics are described
in detail in an additional file (Additional file 2). Fourteen
of the BT 1A Genetic group 2 strains expressed homo-
polymeric O-PS subtype A2 LPS, similar to LPS of sero-
type O:10 (Table 3). Three of the BT 1A genetic group 2
strains had rough LPS type. The strains of Genetic group
1 and the non-typeable strains expressed a great variety
of LPS types and subtypes. All 77 Y. enterocolitica 4/O:3
and 3/O:3 strains included in the LPS analysis expressed
homopolymeric subtype A3 O-PS and the five Y. entero-
colitica 2/O:9 strains subtype A2 O-PS (Table 3). Three
of the ystB negative strains of BT 1A Genetic group 1
belonged to LPS group A2, two to C1 and one to B1c.
Phage sensitivity of the strains was tested using five
Yersinia specific bacteriophages (Table 4). Most of the
63 bio/serotype 3–4/O:3 strains were sensitive to
φYeO3-12, PY100 and φR1-RT, in addition 7 strains
were sensitive to φ80-81. The single bio/serotype 2/O:9
strain was infected by φR1-RT only. The 273 BT 1A and
non-biotypeable strains representing different LPS-types
showed variable phage sensitivity patterns further dem-
onstrating the heterogeneity of this group of strains.
However, all 17 of the BT 1A Genetic subgroup 2 strains
were resistant to all the tested phages.
Resistance to human serum complement-mediated
killing was most common (99%) in the LPS subtype A3
strains, which included the known pathogenic Y. entero-
colitica serotype O:3 strains (Table 5). Of the strains in
the LPS subtype C2, which included the BT 1A/O:5 iso-
lates, 87% were serum resistant. Serum resistance was
also high (67%) among subtype C1 strains, which
included BT 1A strains with similar LPS-structure to
reference strains of serotypes O:6, O:6,30 and O:6,31. Of
the BT 1A LPS subtype A2 (O:10) strains, 72% showed
resistance to complement killing. However, 13 of the 14
(93%) BT 1A Genetic group 2 strains among the LPS
subtype A2 showed high resistance to complement kill-
ing. As a whole, 14 of the 17 (82%) strains of the BT 1A
Genetic group 2 were resistant to serum complement
killing (Figure 2). Among the LPS B-subtypes, which
included a number of the BT1A Genetic group1 isolates,
complement resistance was rather low or non-existing
(Table 5).
Statistical analysis of patient symptoms
The symptoms (diarrhoea, vomiting, fever, abdominal pain
and blood in stools) of patients with BT 1A did not differ
significantly when the statistical analyses were based on
the genetic grouping or serum resistance of the BT 1A
Table 1 Genetic similarity of concatenated seven-gene MLST sequences (4580 bp)
BT 1A
group1
BT 1A
group2
BT 2–4
O:3/O:9
BT 1B
8081
Y.
kristensenii
Y.
frederiksenii
Y.
aldovae
Y.
rohdei
Y.
intermedia
Y.
bercovieri
Y.
mollaretii
Y.
ruckeri
BT 1A Genetic
group1
> 99%
BT 1A Genetic
group2
95–96% > 99%
BT 2–4 O:3/O:9 97% 95% > 99%
BT 1B 8081 97% 95% 98% 100%
Y. kristensenii
ATCC 33638
90% 90% 90% 90% 100%
Y. frederiksenii
ATCC 33641
87% 87% 87% 87% 86% 100%
Y. aldovae
ATCC 35236
87% 87% 87% 87% 87% 85% 100%
Y. rohdei
ATCC 43380
86% 86% 86% 86% 85% 86% 84% 100%
Y. intermedia
ATCC 29909
85% 85% 85% 85% 86% 86% 86% 84% 100%
Y. bercovieri
ATCC 43970
85% 85% 85% 85% 86% 85% 85% 79% 85% 100%
Y. mollaretii
ATCC 43969
86% 86% 86% 86% 86% 86% 85% 79% 85% 91% 100%
Y. ruckeri
ATCC 29473
79–80% 79% 80% 79% 79% 79% 79% 79% 79% 79% 79% 100%
Table 2 Genetic similarity of 16S rRNA gene sequences (1310 bp)
BT 1A
group1
BT 1A
group2
BT2–4
O:3/O:9
BT 1B
8081
Y.
kristensenii
Y.
frederiksenii
Y.
aldovae
Y.
rohdei
Y.
intermedia
Y.
bercovieri
Y.
mollaretii
Y.
ruckeri
BT 1A Genetic
group1
> 99%
BT 1A Genetic
group2
98–99% > 99%
BT 2–4 O:3/O:9 > 99% 98% > 99%
BT 1B 8081 99% 98% 99% 100%
Y. kristensenii
ATCC 33638
98% 99% 98% 98% 100%
Y. frederiksenii
ATCC 33641
98% 98–99% 98% 98% 98.9% 100%
Y. aldovae
ATCC 35236
98% 99% 98% 87% 99.2% 98.6% 100%
Y. rohdei
ATCC 43380
98–99% 98–99% 98–99% 99.2% 98.8% 99% 98.9% 100%
Y. intermedia
ATCC 29909
98% 99% 98% 98% 99% 98.6% 99.4% 98.7% 100%
Y. bercovieri
ATCC 43970
98% 99% 98% 98% 98.8% 98.4% 99.2% 98.5% 99.5% 100%
Y. mollaretii
ATCC 43969
98% 99% 98% 98% 98.9% 98.6% 99.4% 98.6% 99.4% 99.3% 100%
Y. ruckeri
ATCC 29473
97% 98% 97% 97% 98.7% 97.9% 98.1% 97.6% 98% 98.2% 98.2% 100%
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Figure 2 Neighbor joining tree of 16S rRNA gene sequences
(1310 bp) of 47 Yersinia strains. Bootstrap confidence values over
75% (1000 replicates) are given in the branches. sr = serum
resistance, pt = phage type, which encodes reaction to 5 phages
(ϕR1–37, PY100, ϕYeO3–1, ϕR1-RT, ϕ80–81). Strains sequenced in
the present study are marked bold. Strain ATCC9610 is a type strain
of Y. enterocolitica ssp. enterocolitica.
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LPS-groups were symptomatic, but due to the small
amount of patients in analyses, no significant statistical in-
ference could be made.Discussion
The strains previously identified by phenotypic tests to
belong to Y. enterocolitica BT 1A [27] formed two
phylogenetic clusters based on MLST analysis, Genetic
groups 1 and 2. BT 1A Genetic group 1 comprised of
isolates with related 16S rRNA gene sequences but with
great variation in their pathogenicity-associated proper-
ties. On the contrary, BT 1A Genetic group 2 was found
to be rather uniform and phylogenetically distinct from
the other Y. enterocolitica BT 1A strains. The genetic
similarity of this group to Genetic group 1 was 95–96%
based on the MLST sequences and 98–99% based on the
16S rRNA gene sequences. All the 17 strains determined
to belong to Y. enterocolitica BT 1A Genetic group 2
were ystB negative in PCR and were resistant to the five
tested yersiniophages. Additionally, none of them fer-
mented fucose, as determined in our previous study
[27]. Likewise, pathogenic pYV + yersinia strains do not
ferment fucose, whilst 91% of the BT 1A strains other
than those of Genetic group 2 do. Of the Genetic group
2 strains 82% were resistant to serum complement kill-
ing and 76% belonged to LPS type A2.
Remarkably, the 16S rRNA sequences of BT 1A Gen-
etic group 2 were more similar to Y. intermedia, Y. mol-
laretii, Y. aldovae and Y. bercovieri than to Y.
enterocolitica 16S rRNA sequences. However, a previous
study indicated that the use of MLST of house-keeping
genes determined genetic relatedness among Yersiniae
better than 16S rRNA [29]. Studies using both DNA
hybridization and 16S rRNA gene sequence data have
illustrated that if two strains show less than 97% 16S
rRNA gene sequence similarity, they are separate species
[30]. Nevertheless, even 99% similarity of 16S rRNA
genes does not guarantee that bacterial strains represent
the same species. Howard and colleagues [17] have
already suggested that BT 1A strains should be desig-
nated as a third subspecies of Y. enterocolitica based on
the comparison of whole genomes using DNA micro-
array. It is likely that the genetic difference between the
two phylogenetic groups of Y. enterocolitica BT 1A dis-
covered in the present study may also be high enough to
justify designation of different subspecies or even spe-
cies. Although further analyses would be needed for spe-
cies designation, our data add insight into the phylogeny
of the genus Yersinia, which is continuously evolving:
three novel Yersinia species, Y. entomophaga, Y. pekka-
nenii and Y. nurmii were described as recently as 2010
[31-33].
This is the first time that two phylogenetic clusters of
Y. enterocolitica BT 1A strains are reported based on the
sequence analysis of house-keeping genes, but similar
results indicating the existence of two main clusters of
BT 1A strains have been obtained with other molecular
methods, such as ribotyping and REP-ERIC [21], gyrB-
Table 3 LPS types of 298 Y. enterocolitica BT 1A strains and 84 Y. enterocolitica strains of other biotypes
LPS-type Subtype Descriptionc Commentsd Known O-serotypes with similar LPS [56] No. of strains (n=382)
A. Homopolymeric O-PS
A1a Short O:41(27)43, O:41,43 7
A2b Medium O:10 25
A2 Medium BT 2 strains O:9 5
A3a Long 3
A3 Long BT 3–4 strains O:1, O:2, O:3 77
B. Heteropolymeric O-PS
B1a a, B1b a 2/M/1 B1b strains carry homopolymer O:13,18 8
B1c a, B1d a 2+w/M/1–2 B1d strains carry homopolymer O:25 9
B2a a, B2b a 2/L/1 B2b strains carry homopolymer O:7,8, O:13,7 22
B2c a, B2d a 2+w/L/1–2 B2d strains carry homopolymer O:50 55
B3 a 5–6+w/M/3–6 O:14, O:34, O:4,32 4
B4 a >5/M/7–10 O:4, O:8, O:21, O:35,52 1
C. Single length O-PS
C1 a, SL 15-mer O:6, O:6,30, O:6,31 109
C2 a SL 30-mer O:5, O:5,27 45
D. Rough or semi-rough
D a May include rough laboratory
mutants
O:15, O:28,50, O:35,36 12
a Biotype 1A, Genetic group 1.
b Biotype 1A, Genetic group 2.
c Homopolymeric O-PS length estimated by migration in DOC-PAGE; heteropolymeric O-PS is described by X/Y/Z, where X = number of steps in O-PS ladder (+ w indicates a
faint extra step); Y = size of step (M, medium; L, long); Z = average modality of steps; Single length O-PS migrates as one band with estimated number of sugar residues.
d The biotype of the strains is 1A unless otherwise indicated. The presence of homopolymeric O-PS was visible as a smear above the short ladders and not always
easy to distinguish in silver-stained DOC-PAGE gels.
Sihvonen et al. BMC Microbiology 2012, 12:208 Page 6 of 11
http://www.biomedcentral.com/1471-2180/12/208RFLP [22], AFPL [16], MLEE [23,24] and, most re-
cently, MALDI-TOF mass spectrometry to identify the
protein mass patterns [25]. Gulati and Virdi [22] found
in their study that sequences of gyrB genes ofTable 4 Phage sensitivities of 273 Y. enterocolitica BT 1A stra
Bio/serotype, LPS-type, Genetic group
(number of strains) фR1–37
4/O:3, A3 (n = 63) 0
2/O:9, A2 (n = 1) 0
1A, A2, Genetic group 1* (n = 16) 2
1A, A2, A3 or D1, Genetic group 2* (n = 17) 0
1A, A3, Genenetic group 1* (n = 2) 0
1A, B1a or B1b (n = 7) 0
1A, B1c or B1d (n = 7) 0
1A, B2a or B2b (n = 20) 1
1A, B2c or B2d (n = 51) 0
1A, B3 (n = 3) 0
1A, B4 (n = 1) 1
1A, C1 (n = 98) 0
1A/O:5, C2 (n = 41) 5
1A, D1, Genetic group 1* (n = 10) 4
*Genetic group 1 or 2 as defined by MLST.representative two clonal groups of BT 1A strains were
only 97% similar. When we compared these gyrB
sequences to our data, sequences DQ140396 and
DQ140397 [22] were clustered with BT 1A Geneticins and 64 Y. enterocolitica strains of other biotypes
Number of sensitive strains
PY100 фYeO3–12 фR1-RT ф80–81
59 63 61 7
0 0 1 0
9 0 1 0
0 0 0 0
1 0 0 0
2 0 0 0
6 0 0 0
11 1 2 1
51 0 2 20
3 0 0 1
0 0 1 0
38 0 9 0
30 1 13 0
10 1 3 0
Table 5 Serum resistance distribution among different LPS-types of 298 Y. enterocolitica BT 1A strains and 83 Y.
enterocolitica strains of other biotypes
LPS-type 0 (all dead) + (0.01-5%) ++ (5–50%) +++ (> 50%) No. of strains (n = 381)
A1 (O:41(27)43; O:41, 43)a 3 2 2 0 7
A2 (O:10) d 6 1 4 1 12
A2 (O:10) Gen. group 2 1 2 9 1 13
A2 (BT 2/O:9)b 1 3 1 0 5
A3 (O:1; O:2; O:3) 1 0 0 1 2
A3 (O:1; O:2; O:3) Gen. group 2 1 0 0 0 1
A3 (BT 3–4/O:3)b 1 4 25 46 76
B1 (O:13,18; O:25) 10 2 3 2 17
B2 (O:7,8; O:13,7; O:50) c 70 4 2 1 77
B3 (O:14; O:34; O:4,32) 3 1 0 0 4
B4 (O:4; O:8; O:21; O:35,42) 1 0 0 0 1
C1 (O:6; O:6,30; O:6,31)d 36 33 35 5 109
C2 (BT 1A/O:5)b 6 10 15 14 45
D (rough/semi-rough) 8 1 0 0 9
D (rough/semi-rough) Gen. group 2 1 0 2 0 3
The strains belong to biotype 1A and Genetic group 1 unless otherwise indicated.
a The known serotypes with similar LPS structure shown in parenthesis.
b Serotype confirmed with agglutination test.
c Serotype confirmed with O:8 agglutination test for 56 strains.
d This group contains one non-biotypeable Y. enterocolitica strain.
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ther justification for the separation of BT 1A strains
into two phylogenetic lineages. As in our study, the
presence of ystB gene correlated with the clonal
groups, except in one strain [34]. The lack of the ystB
gene in PCR test does not always correlate with the
phylogenetic lineages, since our study also found six
strains without the ystB gene in BT 1A Genetic group
1. However, only the use of hybridization analysis or
sequencing would confirm the PCR results. In a recent
study of the whole genome sequences no evident
structural difference was found with ystB-positive BT
1A/O:5 and BT 1A/O:36 strains [26]. Therefore, it is
likely that the two whole genome sequences represent
one of the genetic groups of BT 1A of the present
study. Blast searches showed that the sequences we
obtained for Genetic group 1 were nearly identical
with the ones from the above mentioned whole gen-
ome sequences, while for Genetic group 2 no match-
ing sequences were detected.
We used DOC-PAGE based classification of LPS to sub-
type our Y. enterocolitica strains. This method offered a
practical substitute for O-serotyping, since there are no
commercial O-specific antisera available for numerous Y.
enterocolitica serotypes. The results were consistent with
earlier O-serotyping of the BT 1A strains using available
commercial antisera [27] which demonstrated that 42subtype C2 strains were of serotype O:5 and that 56
subtype B2 strains agglutinated with anti-O:8 antiserum
indicating that they probably were of the common sero-
type O:7,8. However, the strains with O:8 antigen, were
found in LPS subgroups B2c and B2d which indicates that
the classification of subgroups of B2 was tentative and dif-
ferences could also be inherent to the silver staining pro-
cedure. The clinical BT 1A strains showed a wide diversity
in their LPS types and this is most likely also reflected in
their O-serotypes. The majority of the strains, 37%, had
LPS subtype C1 that is similar to that of serotypes O:6,30
and O:6,31, and 15% of the strains had subtype C2, i.e.,
that of serotype O:5. Globally, the serotypes O:6 and O:5
have been the dominant serotypes of BT 1A associated
with diarrhoea [20]. In the present study the strains of
LPS subtype C1 and C2 as well as the strains of BT 1A
Genetic group 2, demonstrated significant resistance to
complement killing, which suggests that the strains of
these subgroups may have more pathogenic potential than
the other studied strains. Bacterial pathogens have several
strategies to resist host defence mechanisms, including re-
sistance to the bactericidal activity of the human serum
complement [35]. Pathogenic Y. enterocolitica 4/O:3
strains are able to resist serum killing by YadA- and
Ail-mediated binding of the serum complement regulatory
proteins factor H and C4 binding protein [36-38]. The BT
1A strains of the present study did not possess the yadA
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resistance to complement killing of these BT 1A strains
must have another, unresolved mechanism.
Although the potential pathogenicity of BT 1A strains
remains controversial, there are a few studies that show
an association to disease. For instance, BT 1A/O:6,30
was associated with spondyloarthropaties of patients in
England and South-Wales [5]. Also, in a study of anti-
body production, it was found that a patient with symp-
toms of diarrhoea and reactive arthritis had IgG, IgA
and IgM antibodies against the BT 1A/O:6 strain iso-
lated from her fecal sample [6]. We found symptomatic
patients with isolates of both BT 1A genetic groups, but
did not find statistical differences between the genetic
groups and the clinical picture of the symptoms of these
patients. It may be that the patients’ genetic or other fac-
tors such as gut environment are relevant in the disease
caused by BT 1A strains.
Conclusions
The results of our study present strong evidence that
strains classified as Y. enterocolitica BT 1A represent more
than one subspecies. BT 1A Genetic group 1 consisted of
strains with a variety of pathogenicity-related properties,
whereas all 17 strains of BT 1A Genetic group 2 lacked
the ystB gene, belonged either to the same LPS subtype or
were rough, were all resistant to the five tested yersinio-
phages and were largely resistant to serum complement
killing. Furthermore, none of them fermented fucose. Al-
though several studies have been conducted to reveal the
significance of the BT 1A strains in causing disease, indis-
putable results have not been obtained. This study shows,
however, that BT 1A is a very heterogenous group of
strains, some of which might be potential pathogens.
Therefore, better understanding of the genetic and pheno-
typic variability and clustering of these strains, as achieved
in our study, would be crucial in determining the patho-
genic role of the strains belonging to the defined clusters.
Methods
Bacterial strains
Altogether 298 BT 1A, 75 bioserotype 4/O:3, two 3/O:3,
five 2/O:9 and two non-biotypable Y. enterocolitica
strains isolated in 2006 from human samples [27] were
utilized in the study. Only one strain per person was
included in the study.
MLST sequencing
MLST analysis was done on 53 Y. enterocolitica strains
(43 BT 1A and 10 BT’s 2–4 strains) that represented
various LPS patterns. Additionally, two reference strains,
NCTC11174 (O:9) and NCTC11176 (O:3), were
included in the analysis. Genomic DNA was extracted
using Jetflex Genomic DNA purification kit (Genomed,Löhne, Germany). Fragments of seven house-keeping
genes (adk, argA, aroA, glnA, gyrB, thrA, trpE) were
amplified by PCR. For the adk, argA, aroA, glnA, thrA
and trpE genes, the primers available in the MLST data-
base for Y. pseudotuberculosis at the ERI, University
College Cork, were used (http://mlst.ucc.ie/mlst/dbs/
Ypseudotuberculosis/documents/primersPseudotubercu-
losis_html). The gyrB gene amplification was done with
the primers described earlier [29]. The 25 μl amplifica-
tion reactions consisted of 0.25 μM of primers, 0.2 mM
dNTP, 2.5 U AmpliTaq Gold (Applied Biosystems, Foster
City, USA) and 10 × buffer supplied with the enzyme.
The thermal cycle consisted of 10 min denaturation at
94°C, followed by 35 cycles of denaturation for 30 s at
94°C, annealing for 30 s at 51°C, and elongation for 30 s
at 72°C and finally for 3 min at 72°C. The PCR frag-
ments were sequenced in both directions with an ABI
3730xl DNA Analyzer (Applied Biosystems). The Diver-
sity indexes for each MLST gene were calculated by
eBURST v3 [40,41]. The MLST sequences of 53 Y. enter-
ocolitica strains obtained in the study were deposited to
EMBL/GenBank database under the accession numbers
HE803367- HE803737.
Analysis of the MLST data
Population genetic analyses were performed using BAPS
(Bayesian Analysis of Population Structure) software
[42-44] with the second-order Markov model and the
standard MLST data input option as in, e.g., [45,46]. The
optimal number of clusters was calculated using 10 runs
of the estimation algorithm with the prior upper bound
of the number of clusters varying in the range (5,15)
over the 10 replicates. All estimation runs resulted in an
identical partition of the sequence type data with 4 clus-
ters (estimated P = 1.000). Admixture analysis was done
using 100 Monte Carlo replicates for allele frequencies
and by generating 100 reference genotypes to calculate
p-values. For reference cases we used 10 iterations in es-
timation according to the guidelines of [44,47].
Mosaicism is defined as sequence types composed of
sequence characteristic of more than one BAPS group.
Significance of admixture or mosaicism was determined
for each sequence type using the threshold p < 0.05.
Maximum likelihood tree was constructed by using
the concatenated sequences under the general time-
reversible model as implemented in the MEGA5 soft-
ware [48].
16S RNA gene sequencing and tree construction
16S rRNA gene sequencing was obtained for 36 Y. enter-
ocolitica BT 1A strains with the primers FD1mod [49],
pHr, pDf, and pEr [50] in conditions described earlier
[22]. The sequences were used to construct a
Neighbour-joining tree using Phylip [51]. The 16S rRNA
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obtained during this study were deposited to the EMBL/
GenBank database under the accession numbers
HE803738 - HE803765. Eight of the BT 1A strains were
sequenced during our previous studies and have acces-
sion numbers FM958217 - FM958223 and FN812721
[27].
ystA and ystB PCR
For the ystA gene specific PCR the forward primer 3-ATC
GAC ACC AATAAC CGC TGAG −5 and reverse primer
3- CCA ATC ACT ACT GAC TTC GGCT −5 were used
for 38 Y. enterocolitica BT 1A strains. For the ystB gene
specific PCR the forward primer 3-GTA CAT TAG GCC
AAG AGA CG −5 [52] and the reverse primer 3-GCA
ACA TAC CTC ACA ACA CC −5 [53] were used for 298
Y. enterocolitica BT 1A strains. Chromosomal DNA was
used as a template; the conditions for PCR amplification
were as described earlier [52].
DOC-PAGE analysis of LPS
LPS samples of 298 Y. enterocolitica BT 1A strains were
prepared by the small scale proteinase K method as
described earlier [54]. Briefly, the bacteria were grown
for 14–16 h with shaking in 2 ml of LB at 22°C (RT); the
OD600 was determined, the bacteria were then pelleted
by centrifugation, and the pellet was re-suspended in
DOC lysis buffer (2% DOC, 4% 2-mercaptoethanol, 10%
glycerol and 0.002% bromophenol blue in 1 M Tris–HCl
buffer, pH 6.8) in a volume adjusted according to the
density of the culture (i.e., 100 μl / OD600 =1). The sus-
pension was heated to 100°C for 10 min and then 2–4 μl
of proteinase K (20 mg/ml) was added and the suspen-
sion was incubated overnight at 60°C. An aliquot of
10 μl was loaded on the gel and analysed in 12% DOC-
PAGE and the LPS bands were visualized by silver stain-
ing as described earlier [55]. The DOC-PAGE-based LPS
classification of Y. enterocolitica and Y. enterocolitica –
like bacteria has been described elsewhere [56]. Briefly,
based on the O-polysaccharide (O-PS) the strains are
classified into four main LPS types: (i) type A, LPS with
homopolymeric O-PS, (ii) type B, LPS with ladder-
forming heteropolymeric O-PS, (iii) type C, LPS with
single-length O-PS, and (iv) type D, rough or semi-
rough LPS without O-PS or with a lipid A core substi-
tuted with a single O-repeat unit, respectively.
Phage sensitivity assay
The following bacteriophages were used in the typing
scheme: фR1–37 [57,58] that infects Yersinia expressing
the outer core hexasaccharide in LPS; PY100 that infects
a broad range of Yersinia strains [59]; фYeO3–12 that
uses the Y. enterocolitica serotype O:3 O-PS as receptor
[60,61]; φR1-RT that is a bacteriophage originating fromthe sewage of Turku, Finland and infects Y. enterocoli-
tica serotype O:3 grown at RT (Skurnik, unpublished);
and ф80–18 that is a serotype O:8 O-PS specific phage
[62]. For altogether 273 Y. enterocolitica BT 1A strains,
a 40 μl aliquot from a bacterial culture grown for
14–16 h at RT or 37°C with shaking in LB was mixed
with 3.5 ml of molten 0.4% soft agar adjusted to 50°C,
mixed briefly and poured on an LA plate. After the soft
agar had solidified, 10 μl drops of different phage sus-
pensions (~105 plaque forming units ml-1) were pipetted
onto the surface and the plates were incubated at RT or
37°C 14–16 h. Phage sensitivity was scored as a clear
lysis zone in the soft agar.Complement killing assay
Blood was obtained from healthy human donors who
were devoid of anti-Yersinia antibodies. Sera were
pooled and stored in aliquots at −70°C. The killing assay
for 298 Y. enterocolitica BT 1A strains was performed
essentially as described previously [63]. Briefly, for bac-
tericidal assay, bacteria were grown to stationary phase
overnight in 5 ml of MedECa (MedE: 0.1 g l-1 MgSO4 ×
7H2O, 2 g l
-1 citric acid, 10 g l-1 K2HPO4, 3.5 g l
-1
NaNH4HPO4 × 4H2O and 1 mg l
-1 vitamin B1, supple-
mented with 0.2% glucose, 0.2% casamino acids and
2.5 mM CaCl2) at 37°C without shaking. The cultures
were diluted 1:1000–5000 into PBS to obtain a suspen-
sion of ca. 105 cfu/ml and 10 μl of the suspension was
mixed with 20 μl of normal human serum (NHS) or
heat-inactivated serum (HIS, 30 min at 56°C). After
60 min incubation at 37°C, the complement reaction
was stopped by transferring the tubes on ice and the
addition of 70 μl of ice-cold BHI. Aliquots of 20 μl were
cultured on LA-plates and the surviving bacteria were
counted after 48 hr incubation at RT. The serum bac-
tericidal effect was calculated as the survival percentage
taking the bacterial counts obtained with bacteria incu-
bated in HIS as 100%. The survival was scored as fol-
lows: >50% survival, +++; 5–50% survival, ++; and 0.01–
5% survival, +; and no colonies, 0.Statistical analysis of the symptoms of the patients
We compared the symptoms of diarrhoea, vomiting, fever,
abdominal pain and blood in stools among 98 patients with
a Y. enterocolitica BT 1A isolate, who had answered a ques-
tionnaire about the symptoms [7] and had less than six
weeks from the onset of symptoms to the sample-taking.
Comparisons (Fischer’s exact test) were done among these
patients separately for BT 1A genetic groups 1 and 2 (n =
94 and n = 4); for LPS groups: A1-A3 (n = 5), B1-B4 (n =
41), C1 (n = 37), C2 (n = 10), D1 (n = 5); and for serum re-
sistance groups (n = 46 and n = 52). Analyses were done
with STATA 9.0.
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